Live Breaking News & Updates on First Bristol Myers Squibb

Stay updated with breaking news from First bristol myers squibb. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

外资忙"瘦身",内资抢上市!未来十年,最好的医疗健康产业机会在中国-股票频道-和讯网


  与跨国药企的境遇不同,本土创新药企这边却好消息不断,发展形势一片大好。身为本土创新药企龙头,百济神州宣布科创板IPO审核过会,将成为首家在纳斯达克、港交所与上交所三地上市的全球性生物科技公司。而今日,和黄医药将登陆港交所正式开启港股、纳斯达克、伦敦三地上市模式,据悉后续和黄医药还计划在A股科创板IPO。
  一半是海水,一半是火焰。对此,有业内人士研判认为:跨国药企在华布局似乎陷入了瓶颈期。未来十年,最好的医疗健康产业机会在中国,中国本土创新生物医药将迎来发展新机遇,进入爆发式增长,或将诞生世界级的创新疗法与生物医药公司,与美国并行,成为全球大健康行业创新双引擎。
   ....

United States , New Zealand , Hong Kong , Chen Si , City Of , United Kingdom , Zang King , Bristol Myers Squibb , China Drug Department , Hk Division , Shanghai Stock Exchange , Reuters Introduction , Cross Sinopharm Enterprise , First Bristol Myers Squibb , Cross Country , China Market , Landing Hong Kong , Genesis New , Enterprise Start , Star Kay , China Genesis , Hui Switzerland , Sinopharm Enterprise , Senior Management , China Drug , China Innovation ,